Agenda (PDF - 142 KB)
Meeting Minutes (PDF 668 KB)
Webinar
Transcripts
Day 1
U.S. Preventive Services Task Force – Overview and the transfer of newborn screening topics to the DACHDNC
Iris R. Mabry-Hernandez, MD, MPH
Medical Officer
U.S. Preventive Services Task Force Program
Center for Evidence and Practice Improvement
Agency for Healthcare Research and Quality
Pilot Study Workgroup Update
DACHDNC Work Group on Pilot Studies
Jeff Botkin, MD
Committee Member and Chair of the Pilot Study Workgroup
CDC's Role in the Implementation of Newborn Screening Pilot Programs
Carla Cuthbert, PhD, FACMG, FCCMG
Centers for Disease Control and Prevention
Newborn Screening Pilot Studies
Tiina Urv, PhD
National Institutes of Health
Newborn Screening Pilot Studies in The Newborn Screening Translational Research Network
Michael Watson, PhD, FACMG
Organizational Representative American College of Medical Genetics
In Our Own Words: State Perspectives on Public Health Service, Research and Public Trust
Anne Comeau, PhD
Deputy Director, New England Newborn Screening Program
Professor, Department of Pediatrics, UMass Medical School
Laboratory Procedures and Standards Subcommittee Update – Timely Newborn Screening Project and other projects
Kellie Kelm, PhD
Susan Tanksley, PhD
Condition Review Process – Overview
Joseph Bocchini, MD
Committee Chair
Louisiana State University
Evaluating Harms in the Assessment of Net Benefits: A Framework for Newborn Screening Condition Review
Nancy Green, MD
Condition Review Workgroup
Columbia University Medical Center
Condition Review Update – Adrenoleukodystrophy (ALD)
Alex Kemper, MD, MPH, MS
Condition Review Workgroup
Duke Clinical Research Institute and Department of Pediatrics
Cost and Cost-Effectiveness Analysis
Scott Grosse, PhD
Senior Health Economist
National Center on Birth Defects and Developmental Disabilities
Centers for Disease Control and Prevention
Alex Kemper, MD, MPH, MS
Condition Review Workgroup
Duke Clinical Research Institute and Department of Pediatrics
Lisa Prosser, PhD, MS
Condition Review Workgroup
Child Health Evaluation and Research Unit University of Michigan
Day 2
Final Condition Review of Mucopolysaccharidosis I
Alex Kemper, MD, MPH, MS
Condition Review Workgroup
Duke Clinical Research Institute and Department of Pediatrics
Committee Review of Mucopolysaccharidosis I
eff Botkin, MD, MPH
Committee Member
University of Utah
Stephen McDonough, MD
Committee Member
Sanford Health Bismarck
Persons using assistive technology may not be able to fully access information in these files. For assistance, contact HRSAAccessibility@hrsa.gov.